Trial Information
Single-probe Microwave Ablation of Metastatic Liver Cancer is Highly Variable and Irreproducible
Inclusion Criteria:
- Unresectable metastatic liver cancer
- No invasion of major biliary structures
- No invasion of major vascular structures
- ASA score < 4
- WHO score 0-1
- Pre-operative chemotherapy is allowed
Exclusion Criteria:
- Resectable liver metastases
- Life expectancy less than 3 months
- Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic
instruments or other metal materials
- Coagulopathy with platelet count less than 50000
- Active infectious disease
- Age below 18 years
- Pregnancy of breastfeeding
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Variability of ablation diameters
Outcome Time Frame:
within the first 7 days and 3 months after surgery
Safety Issue:
No
Principal Investigator
Baki Topal, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Universitaire Ziekenhuizen Leuven
Authority:
Belgium: Federal Agency for Medicines and Health Products, FAMHP
Study ID:
kulasMWA1
NCT ID:
NCT00922181
Start Date:
August 2008
Completion Date:
April 2009
Related Keywords:
- Liver Neoplasms
- malignancy
- liver
- microwave
- surgery
- Neoplasms
- Liver Neoplasms